BioSpace News Archive

Press Releases

Phase 3 results for Lilly’s Jaypirca® (pirtobrutinib) in covalent BTK inhibitor pre-treated chronic lymphocytic leukemia or small lymphocytic lymphoma to be presented at the 2024 ASH Annual Meeting

December 9, 2024
·
20 min read
Press Releases

Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising Efficacy and Safety Data in CMML Patients at 2024 American Society of Hematology (ASH) Annual Meeting

December 9, 2024
·
7 min read
Press Releases

New and Updated Data for Genentech’s Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their Potential to Improve Outcomes for People With Lymphoma

December 9, 2024
·
19 min read
Press Releases

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting

December 9, 2024
·
7 min read
Press Releases

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets

December 9, 2024
·
18 min read
Press Releases

Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases

December 9, 2024
·
3 min read
Press Releases

Certis Oncology Solutions Unveils CertisOI Assistant™

December 9, 2024
·
3 min read
Press Releases

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

December 9, 2024
·
7 min read
Press Releases

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

December 9, 2024
·
4 min read
Press Releases

Tonix’s TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

December 9, 2024
·
4 min read